首页> 外文会议>Ganoderma: Genetics, Chemistry, Pharmacology and Therapeutics >The Follow-up Observation Assessment of Medium and Late Phases Cancer Treated by Chinese Ganoderma lucidum Essence (CGLE)
【24h】

The Follow-up Observation Assessment of Medium and Late Phases Cancer Treated by Chinese Ganoderma lucidum Essence (CGLE)

机译:灵芝精(CGLE)治疗中晚期癌症的随访观察评估

获取原文
获取原文并翻译 | 示例

摘要

The Follow-up Observation Assessment of Medium and Late Phases Cancer Treated by Chinese Ganoderma lucidum Essence, as to the follow-up observation results of the treatments to 547 medium and late phases cancer sufferers, analysis and comparison are made in the aspects of surviving period, life quality and death rate etc., and assessment is made on the curative effect of this medicine on the terminal cancer therapy. There is certain referential value for the research on the combination of Chinese traditional and western medicine as well as cancer exterior and interior multi-treatments. Perhaps it has some realistic referential significance to the Combining Substitutional Medicine with Integration Medicine Therapy that is newly proposed.
机译:灵芝精治疗中晚期癌症的随访观察评价,针对547例中晚期癌症患者的治疗随访观察结果,从生存期方面进行分析比较。 ,生活质量和死亡率等,并评估该药物对晚期癌症治疗的疗效。对于中西医结合治疗以及癌症内外结合治疗的研究具有一定的参考价值。也许对新提出的替代医学与综合医学治疗相结合具有一定的现实参考意义。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号